ro7119929
Showing 1 - 1 of 1
Carcinoma, Hepatocellular, Biliary Tract Cancer, Secondary Liver Cancer Trial in Worldwide (RO7119929, Tocilizumab)
Completed
- Carcinoma, Hepatocellular
- +3 more
- RO7119929
- Tocilizumab
-
Duarte, California
- +9 more
Jan 27, 2023